For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Current insights into cannabis for mental health disorders
+Practice
GOODFELLOW GEMS
Current insights into cannabis for mental health disorders
Wednesday 23 October 2024, 12:33 AM

[Image: Esteban López on Unsplash]
Goodfellow Gems #228
Despite increasing clinician and self-prescribed cannabis use for mental illnesses, current knowledge about the efficacy and safety of cannabis-based
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Müller-Vahl KR. Cannabinoids in the treatment of selected mental illnesses: Practical approach and overview of the literature. Pharmacopsychiatry 2024;57(3):104–14.